Overtreatment in couples with unexplained infertility. 2015

F A M Kersten, and R P G M Hermens, and D D M Braat, and A Hoek, and B W J Mol, and M Goddijn, and W L D M Nelen, and
Department of Obstetrics and Gynaecology, Radboud University Medical Center, PO Box 9101, Nijmegen 6500 HB, The Netherlands.

OBJECTIVE What is the percentage of overtreatment, i.e. fertility treatment started too early, in couples with unexplained infertility who were eligible for tailored expectant management? CONCLUSIONS Overtreatment occurred in 36% of couples with unexplained infertility who were eligible for an expectant management of at least 6 months. BACKGROUND Prognostic models in reproductive medicine can help to identify infertile couples that would benefit from fertility treatment. In couples with unexplained infertility with a good chance of natural conception within 1 year, based on the Hunault prediction model, an expectant management of 6-12 months, as recommended in international fertility guidelines, prevents unnecessary treatment. METHODS A retrospective cohort study in 25 participating clinics, with follow-up of all couples who were seen for infertility in 2011-2012. METHODS In all, 9818 couples were seen for infertility in the participating clinics. Couples were eligible to participate if they were diagnosed with unexplained infertility and had a good prognosis of natural conception (>30%) within 1 year based on the Hunault prediction model. Data to assess overtreatment were collected from medical records. Multilevel regression analyses were performed to investigate associations of overtreatment with patient and clinic characteristics. RESULTS Five hundred and forty-four couples eligible for expectant management were included in this study. Among these, overtreatment, i.e. starting medically assisted reproduction within 6 months, occurred in 36%. The underlying quality indicators showed that in 34% no prognosis was calculated and that in 42% expectant management was not recommended. Finally, 16% of the couples for whom a correct recommendation of expectant management for at least 6 months was made, started treatment within 6 months anyway. Overtreatment was associated with childlessness, higher female age and a longer duration of infertility. No associations between overtreatment and clinic characteristics were found. CONCLUSIONS The response rate was low compared with other fertility studies. Evaluation of possible selection bias showed that responders had a higher socio-economic status than non-responders. CONCLUSIONS Our findings show that developing and publishing guideline recommendations on tailored expectant management (TEM) is not enough and that overtreatment still occurs frequently. Future research should focus on tailored efforts to implement guideline recommendations on TEM. BACKGROUND Supported by Netherlands Organisation for Health Research and Development (ZonMW). ZonMW had no role in designing the study, data collection, analysis and interpretation of data or writing of the report. Competing interests: none. BACKGROUND www.trialregister.nl NTR3405.

UI MeSH Term Description Entries
D007246 Infertility A reduced or absent capacity to reproduce. Sterility,Reproductive Sterility,Sterility, Reproductive,Sub-Fertility,Subfertility
D008297 Male Males
D008962 Models, Theoretical Theoretical representations that simulate the behavior or activity of systems, processes, or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Experimental Model,Experimental Models,Mathematical Model,Model, Experimental,Models (Theoretical),Models, Experimental,Models, Theoretic,Theoretical Study,Mathematical Models,Model (Theoretical),Model, Mathematical,Model, Theoretical,Models, Mathematical,Studies, Theoretical,Study, Theoretical,Theoretical Model,Theoretical Models,Theoretical Studies
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D027724 Reproductive Techniques, Assisted Clinical and laboratory techniques used to enhance fertility in humans and animals. Reproductive Technology, Assisted,Assisted Reproductive Technics,Assisted Reproductive Techniques,Assisted Reproductive Technic,Assisted Reproductive Technique,Assisted Reproductive Technologies,Assisted Reproductive Technology,Reproductive Technic, Assisted,Reproductive Technics, Assisted,Reproductive Technique, Assisted,Reproductive Technologies, Assisted,Technic, Assisted Reproductive,Technics, Assisted Reproductive,Technique, Assisted Reproductive,Techniques, Assisted Reproductive,Technologies, Assisted Reproductive,Technology, Assisted Reproductive

Related Publications

F A M Kersten, and R P G M Hermens, and D D M Braat, and A Hoek, and B W J Mol, and M Goddijn, and W L D M Nelen, and
February 1989, British journal of obstetrics and gynaecology,
F A M Kersten, and R P G M Hermens, and D D M Braat, and A Hoek, and B W J Mol, and M Goddijn, and W L D M Nelen, and
May 1985, Fertility and sterility,
F A M Kersten, and R P G M Hermens, and D D M Braat, and A Hoek, and B W J Mol, and M Goddijn, and W L D M Nelen, and
February 1992, Human reproduction (Oxford, England),
F A M Kersten, and R P G M Hermens, and D D M Braat, and A Hoek, and B W J Mol, and M Goddijn, and W L D M Nelen, and
July 1983, Fertility and sterility,
F A M Kersten, and R P G M Hermens, and D D M Braat, and A Hoek, and B W J Mol, and M Goddijn, and W L D M Nelen, and
August 2020, The Canadian journal of urology,
F A M Kersten, and R P G M Hermens, and D D M Braat, and A Hoek, and B W J Mol, and M Goddijn, and W L D M Nelen, and
September 1995, The Journal of reproductive medicine,
F A M Kersten, and R P G M Hermens, and D D M Braat, and A Hoek, and B W J Mol, and M Goddijn, and W L D M Nelen, and
November 2018, Reproductive biomedicine online,
F A M Kersten, and R P G M Hermens, and D D M Braat, and A Hoek, and B W J Mol, and M Goddijn, and W L D M Nelen, and
February 2020, Fertility and sterility,
F A M Kersten, and R P G M Hermens, and D D M Braat, and A Hoek, and B W J Mol, and M Goddijn, and W L D M Nelen, and
June 1987, British journal of obstetrics and gynaecology,
F A M Kersten, and R P G M Hermens, and D D M Braat, and A Hoek, and B W J Mol, and M Goddijn, and W L D M Nelen, and
January 1989, International journal of fertility,
Copied contents to your clipboard!